231: Clinical Outcome after Multicenter, Open-Label Phase II Trial on Post-Surgery Chemoradiation in Combination with Cetuximab in Squamous Cell Carcinoma of the Head and Neck with High-Risk of Locoregional Recurrence
2016
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI